Results 41 to 50 of about 312 (58)

Divergent viral phosphodiesterases for immune signaling evasion. [PDF]

Cell Host Microbe
Doherty EE, Nomburg J, Adler BA, Lopez S, Hsieh K, Price N, Blount N, Doudna JA.   +7 more
europepmc   +1 more source

Genome Editing in Mouse Embryo Using the CRISPR/Cas12i3 System. [PDF]

Int J Mol Sci
He J, Liu J, Yue Y, Wang L, Liu Z, Xi G, An L, Tian J, Wang Y.   +8 more
europepmc   +1 more source

A Golden Gate compatible system for continuous directed evolution in <i>E. coli</i>. [PDF]

Synth Biol (Oxf)
Sparrow Muñoz I, Burgess SJ.
europepmc   +1 more source

Most Promising Emerging Therapies for Pulmonary Fibrosis: Targeting Novel Pathways. [PDF]

Biomedicines
Carriera L, Lipsi R, Dodaj M, Inchingolo R, Smargiassi A, Coppola A, Mari PV, Barone R, Ielo S, Scala R, Richeldi L.   +10 more
europepmc   +1 more source

Plasmid Characteristics Modulate the Propensity of Gene Exchange in Bacterial Vesicles. [PDF]

J Bacteriol, 2019
Tran F, Boedicker JQ.
europepmc   +1 more source

The density of Braun's Lipoprotein determines vesicle production in E. coli. [PDF]

PLoS One
Weaver BP, Zhao F, Gao Y, Boedicker JQ, Haselwandter CA.   +4 more
europepmc   +1 more source

A new era in the treatment of progressive fibrosing interstitial lung diseases. [PDF]

Breathe (Sheff)
Denis A, Tsiri P, Guiot J, Tzouvelekis A.   +3 more
europepmc   +1 more source

Phages carry orphan antitoxin-like enzymes to neutralize the DarTG1 toxin-antitoxin defense system. [PDF]

Nat Commun
Johannesman A, Awasthi LC, Carlson N, LeRoux M.   +3 more
europepmc   +1 more source

Establishment and Its Utility of a Patient-Derived Cell Xenografts (PDCX) Model with Cryopreserved Cancer Cells from Human Tumor. [PDF]

Cells
Kim KY, Lee JM, Lee EJ, Jung D, Goh AR, Choi MC, Jung SG, Park H, Hwang S, Kang H, An HJ.   +10 more
europepmc   +1 more source

Styrene Production in Genetically Engineered Escherichia coli in a Two-Phase Culture. [PDF]

BioTech (Basel)
Noda S, Noda S, Fujiwara R, Mori Y, Dainin M, Shirai T, Kondo A.   +6 more
europepmc   +1 more source